Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Coronavirus Infection (COVID-19) clinical trials

1 of 1 indexed Coronavirus Infection (COVID-19) trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Coronavirus Infection (COVID-19): 1 US clinical trial tracked, 1 recruiting.

Coronavirus Infection (COVID-19) is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Duke University, running 1 of these trials.

Enrollment posture brief

Registry condition coronavirus-infection-covid-19

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Coronavirus Infection (this)100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Coronavirus Infection (COVID-19)

Coronavirus Infection (COVID-19) lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Coronavirus Infection (COVID-19) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Coronavirus Infection (COVID-19) is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Duke University 1 trials

Named interventions

Most-linked intervention names on Coronavirus Infection (COVID-19) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: Drug
1 trials

US sites by state

Facility locations filed on Coronavirus Infection (COVID-19) trials. A trial with sites in several states counts in each.

Maryland 1 trials
Massachusetts 1 trials
Louisiana 1 trials
Kentucky 1 trials
Kansas 1 trials
Indiana 1 trials
Illinois 1 trials
Iowa 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Coronavirus Infection (COVID-19) page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Coronavirus Infection (COVID-19) trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Duke University sponsors the most Coronavirus Infection (COVID-19) trials on record, review their full trial history before evaluating a specific study. See Duke University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Coronavirus Infection (COVID-19) condition card totals 1 registered trials; most-linked intervention The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.